Free Trial
→ Banks aren’t ready for this altcoin—are you? (From Crypto 101 Media) (Ad) Buy AEON Stock  Free AEON Stock Alerts

AEON Biopharma (AEON) SEC Filings & 10K Form

AEON Biopharma logo
$0.91 +0.02 (+2.18%)
Closing price 06/13/2025 04:00 PM Eastern
Extended Trading
$0.89 -0.02 (-2.34%)
As of 06/13/2025 07:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent AEON Biopharma SEC Filings

Export to Excel
DateFilerForm TypeView
06/11/2025
5:04 AM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form DEFR14A
05/30/2025
11:10 AM		AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
Chernett Jorey (Filed by)
Form SCHEDULE 13G
05/23/2025
3:55 PM		AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Sy Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
3:56 PM		AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Oh Chad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
3:57 PM		AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Wilson Alexander Blair (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
4:04 PM		AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Thunen Shelley B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
3:46 PM		AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
FISCHER JOST (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
3:50 PM		AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
FISCHER JOST (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
3:50 PM		AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Carter Eric G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
3:51 PM		AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
PALMISANO ROBERT J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2025
3:50 PM		AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
FISCHER JOST (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2025
6:21 PM		AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
L1 Capital Global Opportunities Master Fund, Ltd. (Filed by)
Form SCHEDULE 13G/A
05/15/2025
5:35 PM		AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
S.H.N. Financial Investments Ltd. (Filed by)
Form SCHEDULE 13G/A
05/15/2025
6:07 AM		AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
Polar Asset Management Partners Inc. (Filed by)
Form SCHEDULE 13G/A
04/29/2025
3:10 PM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form ARS
04/21/2025
3:11 PM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2025
3:02 PM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2025
7:45 AM		AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
Alta Partners LLC (Filed by)
Form SCHEDULE 13G
03/10/2025
5:00 AM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2025
12:51 PM		AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
Dauntless Investment Group, LLC (Filed by)
Form SCHEDULE 13G
02/24/2025
1:01 PM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
3:44 PM		AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
Polar Asset Management Partners Inc. (Filed by)
Form SCHEDULE 13G/A
02/07/2025
3:07 PM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2025
3:45 PM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form DEF 14A
01/22/2025
3:02 PM		AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
PALMISANO ROBERT J (Filed by)
Form SCHEDULE 13D
01/13/2025
3:08 PM		AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
L1 Capital Global Opportunities Master Fund, Ltd. (Filed by)
Form SCHEDULE 13G
01/13/2025
3:14 PM		AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
S.H.N. Financial Investments Ltd. (Filed by)
Form SCHEDULE 13G
01/13/2025
5:00 AM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form PRE 14A
01/08/2025
3:15 PM		AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
BIGGER CAPITAL FUND L P (Filed by)
Form SCHEDULE 13G
01/07/2025
3:05 PM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
5:04 AM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 424B5
01/06/2025
8:00 AM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2025
5:00 AM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 424B5
11/13/2024
3:06 PM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
3:07 PM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
3:08 PM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 424B3
10/07/2024
4:01 PM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
8:04 PM		AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
PALMISANO ROBERT J (Reporting)
Form 4/A
09/04/2024
8:52 PM		AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Carter Eric G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:53 PM		AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Sy Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:58 PM		AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Oh Chad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
The End of Elon Musk…? (Ad)

The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.

Click here to see why the "End of Elon" crowd is about to be wrong again.
09/04/2024
8:58 PM		AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
FISCHER JOST (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:58 PM		AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Wilson Alexander Blair (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:59 PM		AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Forth Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:49 PM		AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
PALMISANO ROBERT J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:51 PM		AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Thunen Shelley B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
11:15 PM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form EFFECT
08/12/2024
3:20 PM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 424B3
08/12/2024
3:15 PM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 10-K/A
08/05/2024
11:15 PM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form EFFECT
07/29/2024
3:11 PM		AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
Grodnensky Oleg (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/23/2024
3:43 PM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form S-1/A
07/09/2024
7:06 AM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:AEON) was last updated on 6/16/2025 by MarketBeat.com Staff
From Our Partners
An AI run of epic proportions is only getting started
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsored
Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...
Paradigm Press | Sponsored
[First Look] Get in before potential 10X AI announcements
Go for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...
Masters in Trading | Sponsored
Billionaires are piling into this gold investment
Billionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scra...
Weiss Ratings | Sponsored
Gold is soaring. Here’s how to get paid from it
Gold just broke through $3,300… And while the headlines shout about price targets, something even more powe...
Investors Alley | Sponsored
When This Happens, You Don’t Wait. You Act.
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
Silicon Valley Gold Rush
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...
Stansberry Research | Sponsored
The one deadline Elon can't afford to miss...
For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...
Brownstone Research | Sponsored